ZMYM3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.399500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.389590E-01
Normal-vs-Stage2
3.876400E-02
Normal-vs-Stage3
2.568300E-02
Normal-vs-Stage4
1.945220E-01
Stage1-vs-Stage2
6.131400E-01
Stage1-vs-Stage3
8.822100E-02
Stage1-vs-Stage4
9.317600E-01
Stage2-vs-Stage3
1.038240E-01
Stage2-vs-Stage4
7.521600E-01
Stage3-vs-Stage4
1.642630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.185900E-02
Normal-vs-AfricanAmerican
3.169800E-02
Normal-vs-Asian
9.454200E-02
Caucasian-vs-AfricanAmerican
4.397600E-01
Caucasian-vs-Asian
9.724800E-01
AfricanAmerican-vs-Asian
5.156600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.080200E-02
Normal-vs-Female
4.498300E-02
Male-vs-Female
6.804000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.730800E-01
Normal-vs-Age(41-60Yrs)
1.874580E-01
Normal-vs-Age(61-80Yrs)
1.691810E-02
Normal-vs-Age(81-100Yrs)
1.615550E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.800000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.177200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.955430E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.884570E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.405800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.113400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.303900E-02
Normal-vs-Daily Drinker
2.546400E-02
Normal-vs-Weekly Drinker
5.546000E-02
Normal-vs-Occasional Drinker
5.529000E-01
Normal-vs-Social Drinker
1.671440E-01
Non Drinker-vs-Daily Drinker
7.925800E-01
Non Drinker-vs-Weekly Drinker
4.544200E-01
Non Drinker-vs-Occasional Drinker
4.183900E-02
Non Drinker-vs-Social Drinker
6.994100E-02
Daily Drinker-vs-Weekly Drinker
6.026800E-01
Daily Drinker-vs-Occasional Drinker
6.358500E-02
Daily Drinker-vs-Social Drinker
1.152160E-01
Weekly Drinker-vs-Occasional Drinker
1.813620E-01
Weekly Drinker-vs-Social Drinker
3.318200E-01
Occasional Drinker-vs-Social Drinker
5.206400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.301400E-01
Normal-vs-Grade 2
1.265570E-01
Normal-vs-Grade 3
6.034300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.026000E-01
Grade 1-vs-Grade 3
3.079000E-01
Grade 1-vs-Grade 4
2.301400E-01
Grade 2-vs-Grade 3
7.263900E-02
Grade 2-vs-Grade 4
1.265570E-01
Grade 3-vs-Grade 4
6.034300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.064360E-02
Normal-vs-NonDiabetic
8.103500E-02
Diabetic-vs-NonDiabetic
1.017430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.141400E-01
Normal-vs-NoPancreatitis
5.079700E-02
Pancreatitis-vs-NoPancreatitis
1.750570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.900000E-02
Normal-vs-N1
3.732200E-02
N0-vs-N1
7.452200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.465370E-01
Normal-vs-TP53-NonMutant
2.221400E-01
TP53-Mutant-vs-TP53-NonMutant
7.504200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
